Mexico City, Jan 27 (Prensa Latina) Mexican health authorities plan to open 80 clinics this year to administer the Cuban drug Heberprot-P, the only one in the world capable of stimulating accelerated granulation and re-epithelialization in diabetic foot ulcers.
“The idea is to open 80 clinics across the country for diabetic foot care this year. We’ve already started in Chiapas and Guerrero. We currently have 12 clinics operating and we’re going to continue expanding,” said Alejandro Svarch, director of IMSS-Bienestar.
During the usual meeting of the president Claudia Sheinbaum with journalists, the official stated from the National Palace that the product is mainly aimed at ulcers in an advanced stage and allows the affected limb to be saved.
He described it as very innovative that this technology can be applied from the first level of care, thus avoiding not only amputation, but also transfer to hospitals.
According to official data, 75 Mexicans have a leg or foot amputated every day due to diseases such as diabetes.
Svarch highlighted the development of the biotechnology industry in Cuba, which allowed it to create its own vaccines against the Covid-19 pandemic, and recalled that one of them was authorized in this North American country.
jha/las
